# Late Feasibility Study to Evaluate Safety and Efficacy of AWAK PD Device in Subjects With ESKD.

> **NCT05827588** · NA · COMPLETED · sponsor: **AWAK Technologies Pte Ltd** · enrollment: 12 (actual)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DEVICE:** AWAK PD

## Key facts

- **NCT ID:** NCT05827588
- **Lead sponsor:** AWAK Technologies Pte Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-31
- **Primary completion:** 2024-03-10
- **Final completion:** 2024-07-29
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05827588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05827588, "Late Feasibility Study to Evaluate Safety and Efficacy of AWAK PD Device in Subjects With ESKD.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05827588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*